SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Mankind Pharma

BSE: 543904 29 Sep 2025
Healthcare
₹ 2579
Mankind Pharma Limited specializes in Pharmaceuticals within the Healthcare sector.

Mankind Pharma - Share Price & Details

Market Cap
₹1,02,484
High /Low
3,055 / 2,115
Stock P/E
54.2
Book Value
₹347.0
Dividend Yield
0.04
ROCE
16.0
ROE
₹14.7
Face Value
1.0
PEG Ratio
6.56
EVEBITDA
₹29.6
Debt
8,511
CMP / FCF
66.1
Debt to equity
₹0.59
NP Ann
2,011
High price all time
3,055
Piotroski score
₹4.0
Graham Number
602.0
No. Eq. Shares
41.3
Net CF
₹21.9
Net profit
1,913
Price to book value
7.15
Interest Coverage
₹5.06
Low price all time
1,241
Industry PE
33.0
Reserves
₹14,291
Free Cash Flow
₹1,895

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
01 Aug 2025 Motilal Oswal Buy ₹2,562.3 ₹2,990 14.1% moneycontrol View
22 May 2025 Motilal Oswal Buy ₹2,533.05 ₹2,910 19.3% moneycontrol View
25 Jan 2025 Motilal Oswal Buy ₹2,505.85 ₹3,050 24.1% moneycontrol View
05 Nov 2024 Motilal Oswal Buy ₹2,714.4 ₹3,140 22.3% moneycontrol View
23 Aug 2024 Motilal Oswal Buy ₹2,361.4 ₹2,760 7.3% moneycontrol View
26 Jul 2024 Motilal Oswal Buy ₹2,054.9 ₹2,650 3.5% moneycontrol View

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
Mankind Pharma Limited26055.84127.625413.69.991,02,48454.2
Zydus Lifesciences Limited27454.03847.025883.03.829810821.1
LUPIN LTD.57627.321280.757085.946.488768823.7

Peer Comparison Chart


About Mankind Pharma

Mankind Pharma Limited, with Security Code 543904, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Mankind Pharma Shows Resilience Amid Market Fluctuations and Positive Momentum Indicators

(18 Sep 2025)
Mankind Pharma has demonstrated resilience in the market, gaining 3.51% on September 18, 2025, after a series of declines. The stock is trading above key...
Read more →

Mankind joins hands with OpenAI to integrate advanced AI into core operations

(18 Sep 2025)
Since July 2025, Mankind Pharma has deployed a wide range of customised GPTs across its workforce, notably enhancing the effectiveness of...
Read more →

Mankind joins hands with OpenAI to institutionalise AI in operations

(18 Sep 2025)
Delhi-based pharma major Mankind Pharma on Wednesday announced a collaboration with OpenAI to institutionalise artificial intelligence (AI)...
Read more →

Mankind Pharma collaborates with OpenAI to build agile supply chains, research

(18 Sep 2025)
Mankind Pharma collaborates with OpenAI to integrate AI across its value chain for improved efficiency and innovation.
Read more →

Mankind Pharma, OpenAI Partner for AI Transformation

(18 Sep 2025)
Mankind Pharma teams up with OpenAI to infuse AI across the pharma value chain, boosting innovation, efficiency, and patient care.
Read more →

Mankind Pharma partners with OpenAI to integrate AI across operations

(18 Sep 2025)
The collaboration will see the use of ChatGPT in areas such as research and development, manufacturing, digital marketing,...
Read more →